Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods

Respiratory syncytial virus (RSV) is a massive medical burden on a global scale. Infants, children and the elderly represent the vulnerable populations. Currently there is no approved vaccine to protect against the disease. Vaccine development has been hindered by several factors including vaccine e...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Trevor R. F., Schultheis, Katherine, Broderick, Kate E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703370/
https://www.ncbi.nlm.nih.gov/pubmed/28881156
http://dx.doi.org/10.1080/21645515.2017.1363134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703370/
https://www.ncbi.nlm.nih.gov/pubmed/28881156
http://dx.doi.org/10.1080/21645515.2017.1363134

Ejemplares similares